| Product Code: ETC7653172 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Hematology Oncology Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Hematology Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Hematology Oncology Market - Industry Life Cycle |
3.4 Israel Hematology Oncology Market - Porter's Five Forces |
3.5 Israel Hematology Oncology Market Revenues & Volume Share, By Hematology Product, 2021 & 2031F |
3.6 Israel Hematology Oncology Market Revenues & Volume Share, By Oncology Drug Class Type, 2021 & 2031F |
3.7 Israel Hematology Oncology Market Revenues & Volume Share, By Oncology Indication, 2021 & 2031F |
3.8 Israel Hematology Oncology Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.9 Israel Hematology Oncology Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Israel Hematology Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hematologic and oncologic diseases in Israel |
4.2.2 Technological advancements in hematology oncology treatments |
4.2.3 Growing investments in healthcare infrastructure in Israel |
4.3 Market Restraints |
4.3.1 High cost of hematology oncology treatments |
4.3.2 Stringent regulations and reimbursement policies in Israel |
5 Israel Hematology Oncology Market Trends |
6 Israel Hematology Oncology Market, By Types |
6.1 Israel Hematology Oncology Market, By Hematology Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Hematology Oncology Market Revenues & Volume, By Hematology Product, 2021- 2031F |
6.1.3 Israel Hematology Oncology Market Revenues & Volume, By Hematology Analyzers, 2021- 2031F |
6.1.4 Israel Hematology Oncology Market Revenues & Volume, By Hematology Reagents, 2021- 2031F |
6.1.5 Israel Hematology Oncology Market Revenues & Volume, By Flow Cytometers, 2021- 2031F |
6.1.6 Israel Hematology Oncology Market Revenues & Volume, By Hematology Cell Counters, 2021- 2031F |
6.1.7 Israel Hematology Oncology Market Revenues & Volume, By Slide Strainers, 2021- 2031F |
6.1.8 Israel Hematology Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Hematology Oncology Market, By Oncology Drug Class Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Hematology Oncology Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.3 Israel Hematology Oncology Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.2.4 Israel Hematology Oncology Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.2.5 Israel Hematology Oncology Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.3 Israel Hematology Oncology Market, By Oncology Indication |
6.3.1 Overview and Analysis |
6.3.2 Israel Hematology Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.3.3 Israel Hematology Oncology Market Revenues & Volume, By Stomach Cancer, 2021- 2031F |
6.3.4 Israel Hematology Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.3.5 Israel Hematology Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.3.6 Israel Hematology Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.4 Israel Hematology Oncology Market, By Applications |
6.4.1 Overview and Analysis |
6.4.2 Israel Hematology Oncology Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.4.3 Israel Hematology Oncology Market Revenues & Volume, By Cancer, 2021- 2031F |
6.4.4 Israel Hematology Oncology Market Revenues & Volume, By Cardiovascular Disorders, 2021- 2031F |
6.4.5 Israel Hematology Oncology Market Revenues & Volume, By Blood Screening, 2021- 2031F |
6.4.6 Israel Hematology Oncology Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.4.7 Israel Hematology Oncology Market Revenues & Volume, By HIV, 2021- 2031F |
6.5 Israel Hematology Oncology Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Hematology Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Hematology Oncology Market Revenues & Volume, By Clinical Testing Institutes, 2021- 2031F |
6.5.4 Israel Hematology Oncology Market Revenues & Volume, By Patient Self-Testing, 2021- 2031F |
6.5.5 Israel Hematology Oncology Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Hematology Oncology Market Import-Export Trade Statistics |
7.1 Israel Hematology Oncology Market Export to Major Countries |
7.2 Israel Hematology Oncology Market Imports from Major Countries |
8 Israel Hematology Oncology Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rate of new hematology oncology therapies |
8.3 Number of clinical trials and research studies conducted in Israel |
8.4 Patient satisfaction and quality of life improvements |
8.5 Rate of early detection and diagnosis of hematologic and oncologic diseases |
9 Israel Hematology Oncology Market - Opportunity Assessment |
9.1 Israel Hematology Oncology Market Opportunity Assessment, By Hematology Product, 2021 & 2031F |
9.2 Israel Hematology Oncology Market Opportunity Assessment, By Oncology Drug Class Type, 2021 & 2031F |
9.3 Israel Hematology Oncology Market Opportunity Assessment, By Oncology Indication, 2021 & 2031F |
9.4 Israel Hematology Oncology Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.5 Israel Hematology Oncology Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Israel Hematology Oncology Market - Competitive Landscape |
10.1 Israel Hematology Oncology Market Revenue Share, By Companies, 2024 |
10.2 Israel Hematology Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here